Glaukos Corporation is a leading ophthalmic medical technology and pharmaceutical company dedicated to improving the lives of patients with glaucoma. Through the development of innovative therapies, Glaukos has become a trusted name in the field, offering effective solutions for patients and clinicians alike. The company’s commitment to research and development ensures that they continue to deliver cutting-edge products to the market.